• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.

    11/14/24 5:20:21 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care
    Get the next $PRVA alert in real time by email
    SC 13G/A 1 privia-sc13ga_093024.htm AMENDMENT TO SC 13G Proof - warby-sc13ga_093024.htm

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

    ______________

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

     

    (Amendment No. 1)*

     

    Privia Health Group, Inc.

    (Name of Issuer)

     

    Common Stock, $0.01 par value per share

    (Title of Class of Securities)

     

    74276R102

    (CUSIP Number)

     

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No. 74276R102

     




    1

    NAMES OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Durable Capital Partners LP

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

    (a)       ☐

    (b)       ☐

     

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH:
    5

    SOLE VOTING POWER

     

    11,109,588

    6

    SHARED VOTING POWER

     

    0       

     

    7

    SOLE DISPOSITIVE POWER

     

    11,109,588

     

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    11,109,588

     

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    9.3%

     

    12

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

    IA, PN

     

                     

     

     

     

    Item 1(a).Name of Issuer:

     

    Privia Health Group, Inc. (the “Issuer”)

     

    Item 1(b).Address of Issuer’s Principal Executive Offices:

     

    950 N. Glebe Rd., Suite 700

    Arlington, Virginia 22203

     

    Item 2(a).Names of Person Filing:

     

    The name of the person filing this report is:

    Durable Capital Partners LP (the “Reporting Person”)

     

    Item 2(b).Address of Principal Business Office or, if None, Residence:

     

    The address of the principal business office of the Reporting Person is:

    4747 Bethesda Avenue, Suite 1002

    Bethesda, Maryland 20814

     

    Item 2(c).Citizenship or Place of Organization:

     

    The Reporting Person is a limited partnership organized under the laws of the State of Delaware.

     

    Item 2(d).Title of Class of Securities:

     

    Common Stock, $0.01 par value per share (“Common Stock”)

     

    Item 2(e).CUSIP Number:

     

    74276R102

     

    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

     

    (b)☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

     

    (c)☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

     

    (d)☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

     

    (e)☒ An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E).

     

    (f)☐ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).

     

     

     

     

    (g)☐ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).

     

    (h)☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).

     

    (i)☐ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).

     

    (j)☐ A non-U.S. institution that is the functional equivalent of any of the institutions listed in § 240.13d-1 (b)(1)(ii)(A) through (I), so long as the non-U.S. institution is subject to a regulatory scheme that is substantially comparable to the regulatory scheme applicable to the equivalent U.S. institution.

     

    (k)☐ Group, in accordance with §240.13d-1(b)(1)(ii)(K).

     

    Item 4.Ownership.

     

    The information required by this item with respect to the Reporting Person is set forth in Rows 5 through 9 and 11 of the cover page to this Schedule 13G. The ownership percentages reported are based on 119,564,972 outstanding shares of voting Common Stock as of August 2, 2024, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on August 8, 2024.

     

    Durable Capital Master Fund LP directly holds 6,564,134 shares of Common Stock and Durable Capital Opportunities Fund LP directly holds 4,545,454 shares of Common Stock (together, the “Shares”). The Reporting Person, as the investment adviser to Durable Capital Master Fund LP and Durable Capital Opportunities Fund LP, has sole power to direct the vote and disposition of the Shares. Durable Capital Partners GP LLC (“Durable GP”) is the general partner of the Reporting Person, and Henry Ellenbogen is the chief investment officer of the Reporting Person and the managing member of Durable GP.

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

    Inapplicable.

     

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

     

    See disclosure of relationships among parties under Item 4. The economic benefits of the Shares are shared based on agreements among the parties.

     

    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

     

    See control and Shares holding disclosure in Item 4.

     

    Item 8.Identification and Classification of Members of the Group.

     

    Inapplicable.

     

     

     

     

    Item 9.Notice of Dissolution of Group.

     

    Inapplicable.

     

    Item 10.Certification.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Date:November 14, 2024

     

    DURABLE CAPITAL PARTNERS LP

     

    By: /s/ Julie Jack  
    Name:Julie Jack
    Title:Authorized Person

     

     

    Get the next $PRVA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PRVA

    DatePrice TargetRatingAnalyst
    1/10/2025$25.00Buy
    Needham
    12/16/2024Outperform
    Macquarie
    10/11/2024$23.00Overweight
    KeyBanc Capital Markets
    5/30/2024$23.00Outperform
    Robert W. Baird
    4/22/2024$25.00Buy
    Citigroup
    3/6/2024$22.00Equal Weight
    Barclays
    2/26/2024$33.00 → $25.00Buy
    Jefferies
    2/22/2024$21.00Buy → Neutral
    BofA Securities
    More analyst ratings

    $PRVA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Privia Health Reports First Quarter 2025 Financial Results

      Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged ARLINGTON, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the first quarter ended March 31, 2025.   Three Months Ended March 31,  ($ in millions, except per share amounts) 2025 2024 Change (%)*       Total revenue $480.1 $415.2 15.6%Gross profit $103.6 $93.4 11.0%Operating income $5.2 $0.8 534.0%Net income a $4.2 $3.0 41.4%Non-GAAP adjusted net income b d e $27.8 $22.5 23.3%Net income per share $0.03 $0.02 50.0%Non-GAAP adju

      5/8/25 6:00:00 AM ET
      $PRVA
      Medical/Nursing Services
      Health Care
    • Privia Health Enters Arizona In Partnership with Integrated Medical Services

      IMS is One of the Largest Independent Multi-Specialty Practices in the State Arizona Represents 15th State in National Primary Care-Centric Care Delivery Network ARLINGTON, Va., April 09, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced it has signed a definitive agreement to enter Arizona in partnership with Integrated Medical Services, Inc. (IMS), one of the largest independent multi-specialty practices in the state, with approximately 70 physicians and advanced practice providers caring for patients in 21 locations. The group manages over 28,000 attributed lives in a variety of value-based care arrangements across Commercial, Medicare, Medicare Advantage and

      4/9/25 9:00:00 AM ET
      $PRVA
      Medical/Nursing Services
      Health Care
    • Privia Health to Report First Quarter 2025 Results on Thursday, May 8

      ARLINGTON, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2025 before market open on Thursday, May 8, 2025. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, May 8, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/events-and-presentations t

      4/8/25 9:00:00 AM ET
      $PRVA
      Medical/Nursing Services
      Health Care

    $PRVA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Boehler Adam bought $6,006 worth of shares (364 units at $16.50) (SEC Form 4)

      4 - Privia Health Group, Inc. (0001759655) (Issuer)

      6/13/24 4:05:22 PM ET
      $PRVA
      Medical/Nursing Services
      Health Care
    • Boehler Adam bought $87,549 worth of shares (5,306 units at $16.50) (SEC Form 4)

      4 - Privia Health Group, Inc. (0001759655) (Issuer)

      5/31/24 4:13:08 PM ET
      $PRVA
      Medical/Nursing Services
      Health Care
    • Boehler Adam bought $70,577 worth of shares (4,280 units at $16.49) (SEC Form 4)

      4 - Privia Health Group, Inc. (0001759655) (Issuer)

      5/29/24 4:08:14 PM ET
      $PRVA
      Medical/Nursing Services
      Health Care

    $PRVA
    Leadership Updates

    Live Leadership Updates

    See more
    • Privia Health Appoints Edward C. Fargis as General Counsel

      ARLINGTON, Va., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective today. Mr. Fargis will serve as the Company's chief legal officer, working with Privia executive leadership to support the Company's long-term direction and growth. "Ed is a proven leader who brings an invaluable healthcare industry perspective as well as extensive experience managing corporate governance, compliance and strategic transactions," said Parth Mehrotra, CEO, Privia Health. "As Privia continues to grow and our industry evolves, we are fortunate to have Ed joining us

      1/29/24 8:30:00 AM ET
      $PRVA
      Medical/Nursing Services
      Health Care
    • Privia Health Announces Leadership Succession

      ARLINGTON, Va., April 12, 2023 (GLOBE NEWSWIRE) -- Privia Health (NASDAQ:PRVA), a technology-driven, national physician enablement company, today announced that Parth Mehrotra, currently the Company's President and Chief Operating Officer, has been named Chief Executive Officer, effective July 1, 2023. Mehrotra is succeeding current CEO, Shawn Morris, who is retiring and will remain on the Company's Board of Directors. Under Morris' leadership since early 2018, Privia Health progressed from a private, regional organization into a publicly-traded company with national reach. During that time, the Company entered eight new states, completed a successful IPO in April 2021, and increased it

      4/12/23 8:00:00 AM ET
      $PRVA
      Medical/Nursing Services
      Health Care

    $PRVA
    SEC Filings

    See more
    • SEC Form DEFA14A filed by Privia Health Group Inc.

      DEFA14A - Privia Health Group, Inc. (0001759655) (Filer)

      5/12/25 7:06:01 AM ET
      $PRVA
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by Privia Health Group Inc.

      10-Q - Privia Health Group, Inc. (0001759655) (Filer)

      5/8/25 9:01:33 AM ET
      $PRVA
      Medical/Nursing Services
      Health Care
    • Privia Health Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Privia Health Group, Inc. (0001759655) (Filer)

      5/8/25 6:06:08 AM ET
      $PRVA
      Medical/Nursing Services
      Health Care

    $PRVA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.

      SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)

      11/14/24 5:20:21 PM ET
      $PRVA
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.

      SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)

      11/12/24 10:34:17 AM ET
      $PRVA
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.

      SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)

      7/10/24 1:14:41 PM ET
      $PRVA
      Medical/Nursing Services
      Health Care

    $PRVA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham initiated coverage on Privia Health with a new price target

      Needham initiated coverage of Privia Health with a rating of Buy and set a new price target of $25.00

      1/10/25 7:58:16 AM ET
      $PRVA
      Medical/Nursing Services
      Health Care
    • Macquarie initiated coverage on Privia Health

      Macquarie initiated coverage of Privia Health with a rating of Outperform

      12/16/24 7:46:21 AM ET
      $PRVA
      Medical/Nursing Services
      Health Care
    • KeyBanc Capital Markets initiated coverage on Privia Health with a new price target

      KeyBanc Capital Markets initiated coverage of Privia Health with a rating of Overweight and set a new price target of $23.00

      10/11/24 7:52:57 AM ET
      $PRVA
      Medical/Nursing Services
      Health Care

    $PRVA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Mehrotra Parth sold $734,276 worth of shares (29,682 units at $24.74), decreasing direct ownership by 7% to 407,234 units (SEC Form 4)

      4 - Privia Health Group, Inc. (0001759655) (Issuer)

      5/14/25 6:05:53 PM ET
      $PRVA
      Medical/Nursing Services
      Health Care
    • EVP & Chief Financial Officer Mountcastle David sold $83,017 worth of shares (3,322 units at $24.99), decreasing direct ownership by 2% to 172,909 units (SEC Form 4)

      4 - Privia Health Group, Inc. (0001759655) (Issuer)

      5/14/25 6:05:10 PM ET
      $PRVA
      Medical/Nursing Services
      Health Care
    • EVP & Chief Financial Officer Mountcastle David sold $80,372 worth of shares (3,445 units at $23.33), decreasing direct ownership by 2% to 176,231 units (SEC Form 4)

      4 - Privia Health Group, Inc. (0001759655) (Issuer)

      5/2/25 5:01:16 PM ET
      $PRVA
      Medical/Nursing Services
      Health Care

    $PRVA
    Financials

    Live finance-specific insights

    See more
    • Privia Health Reports First Quarter 2025 Financial Results

      Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged ARLINGTON, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the first quarter ended March 31, 2025.   Three Months Ended March 31,  ($ in millions, except per share amounts) 2025 2024 Change (%)*       Total revenue $480.1 $415.2 15.6%Gross profit $103.6 $93.4 11.0%Operating income $5.2 $0.8 534.0%Net income a $4.2 $3.0 41.4%Non-GAAP adjusted net income b d e $27.8 $22.5 23.3%Net income per share $0.03 $0.02 50.0%Non-GAAP adju

      5/8/25 6:00:00 AM ET
      $PRVA
      Medical/Nursing Services
      Health Care
    • Privia Health to Report First Quarter 2025 Results on Thursday, May 8

      ARLINGTON, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2025 before market open on Thursday, May 8, 2025. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, May 8, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/events-and-presentations t

      4/8/25 9:00:00 AM ET
      $PRVA
      Medical/Nursing Services
      Health Care
    • Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results

      All 2024 Operating and Financial Metrics Above High End of Guidance RangesVery strong New Provider Signings with Implemented Providers +11.2% from Year-end 2023Full-year 2024 Net Cash Provided by Operating Activities of $109.3 million, +35.3% from 2023, with De Minimis Capital ExpendituresYear-end 2024 Cash Balance of $491.1 million and No Debt2025 Guidance Reflects Continued Momentum and Profitable Growth Despite Challenging Medicare Advantage and Value-based Environment ARLINGTON, Va., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2024. Each of the Company'

      2/27/25 6:00:00 AM ET
      $PRVA
      Medical/Nursing Services
      Health Care